Evaluation of Intraocular Anti-vascular Endothelial Growth Factor (VEGF) Drug-Associated Adverse Events Using Spontaneous Reporting Databases
The findings suggest that cerebral infarction may develop earlier with IVR use than with IVA use and highlight the need for careful monitoring and individualized treatment strategies in clinical practice.
Authors
- Yoko Ino (ORCID: https://orcid.org/0000-0003-2195-1385)
- Suang Rungpragayphan
- Sawa Ito (ORCID: https://orcid.org/0000-0002-6076-0234)
- Pornsak Sriamornsak (ORCID: https://orcid.org/0000-0002-5525-1494)
- Keizo Kageyama
- Waranee Bunchuailua
- Tomofumi Yamazaki
- Mitsuhiro Nakamura (ORCID: https://orcid.org/0000-0002-6406-2097)
- Sineenart Krichanchai
- Satoshi Nakao (ORCID: https://orcid.org/0000-0001-7413-2637)
- Maria Notomi Sato (ORCID: https://orcid.org/0000-0002-7911-1824)
- Hirofumi Takeuchi
- Kana Sugishita
Institutions
- Gifu Pharmaceutical University (JP)
- Silpakorn University (TH)
Publication Details
- Journal
- Cureus
- Published
- 2025-09-01
- DOI
- https://doi.org/10.7759/cureus.91376
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00